Stock MGX METAGENOMI, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Metagenomi, Inc.

Equities

MGX

US59102M1045

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
6.38 USD -0.16% Intraday chart for Metagenomi, Inc. -2.60% -.--%
May. 14 Metagenomi, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 07 HC Wainwright Starts Metagenomi With Buy Rating, $10 Price Target MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
GL
Metagenomi: Q1 Earnings Snapshot
AQ
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
GL
Metagenomi, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
HC Wainwright Starts Metagenomi With Buy Rating, $10 Price Target
MT
North American Morning Briefing : Apple, Amgen -2-
DJ
Chardan Research Lowers Metagenomi's PT to $17 From $21 on Heels of Announced Termination of Collaboration With Moderna, Keeps Buy Rating
MT
JPMorgan Downgrades Metagenomi to Neutral, Price Target at $6
MT
Metagenomi, Inc. and Modernatx, Inc. Terminate the Strategic Collaboration and License Agreement
CI
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GL
Metagenomi to Present at Upcoming Scientific Meetings
GL
Metagenomi to Present at Upcoming Scientific Meetings
AQ
Metagenomi 2023 Loss Widens, Revenue Rises
MT
Metagenomi Reports Business Updates and Full Year 2023 Financial Results
GL
Metagenomi, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Metagenomi, Inc.(NasdaqGS:MGX) added to S&P TMI Index
CI
TD Cowen Initiates Metagenomi With Outperform Rating
MT
Jefferies Starts Metagenomi With Buy Rating, $23 Price Target
MT
BMO Capital Starts Metagenomi With Outperform Rating, $22 Price Target
MT
Wells Fargo Starts Metagenomi With Overweight Rating, $25 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MGX Stock
  4. News Metagenomi, Inc.